These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16823938)

  • 1. Sucrose fatty acid sulphate esters as novel vaccine adjuvant.
    Hilgers LA; Blom AG
    Vaccine; 2006 Apr; 24 Suppl 2():S2-81-2. PubMed ID: 16823938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sucrose fatty acid sulphate esters as novel vaccine adjuvants: effect of the chemical composition.
    Blom AG; Hilgers LA
    Vaccine; 2004 Dec; 23(6):743-54. PubMed ID: 15542198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate fatty acid monosulphate esters are safe and effective adjuvants for humoral responses.
    Hilgers LAT; Platenburg PPLI; Bajramovic J; Veth J; Sauerwein R; Roeffen W; Pohl M; van Amerongen G; Stittelaar KJ; van den Bosch JF
    Vaccine; 2017 May; 35(24):3249-3255. PubMed ID: 28479181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfolipo-cyclodextrin in squalane-in-water as a novel and safe vaccine adjuvant.
    Hilgers LA; Lejeune G; Nicolas I; Fochesato M; Boon B
    Vaccine; 1999 Jan; 17(3):219-28. PubMed ID: 9987157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel non-mineral oil-based adjuvant. II. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in pigs.
    Hilgers LA; Platenburg PL; Luitjens A; Groenveld B; Dazelle T; Weststrate MW
    Vaccine; 1994 May; 12(7):661-5. PubMed ID: 8085386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkyl-esters of polyacrylic acid as vaccine adjuvants.
    Hilgers LA; Nicolas I; Lejeune G; Dewil E; Strebelle M; Boon B
    Vaccine; 1998 Oct; 16(16):1575-81. PubMed ID: 9711806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel oil-in-water emulsion and evaluation of its potential adjuvant function in a swine influenza vaccine in mice.
    Zhang J; Miao J; Han X; Lu Y; Deng B; Lv F; Zhao Y; Ding C; Hou J
    BMC Vet Res; 2018 Dec; 14(1):415. PubMed ID: 30577861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel non-mineral oil-based adjuvant. I. Efficacy of a synthetic sulfolipopolysaccharide in a squalane-in-water emulsion in laboratory animals.
    Hilgers LA; Platenburg PL; Luitjens A; Groenveld B; Dazelle T; Ferrari-Laloux M; Weststrate MW
    Vaccine; 1994 May; 12(7):653-60. PubMed ID: 8085385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragalus polysaccharides combined with simvastatin as an immunostimulant enhances the immune adjuvanticity of oil-in-water emulsion and immune responses in mice.
    Xu S; Wu Z; Cai G; Zhang Y; Peng S; Jiao L; Liu Z; Yang Y; Wang D
    Vaccine; 2023 Mar; 41(10):1684-1693. PubMed ID: 36754767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant effects of sulfolipo-cyclodextrin in a squalane-in-water and water-in-mineral oil emulsions for BHV-1 vaccines in cattle.
    Romera SA; Hilgers LA; Puntel M; Zamorano PI; Alcon VL; Dus Santos MJ; Blanco Viera J; Borca MV; Sadir AM
    Vaccine; 2000 Aug; 19(1):132-41. PubMed ID: 10924795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvants for human vaccines--current status, problems and future prospects.
    Gupta RK; Siber GR
    Vaccine; 1995 Oct; 13(14):1263-76. PubMed ID: 8585280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic sulpholipopolysaccharides: novel adjuvants for humoral immune responses.
    Hilgers LA; Snippe H; Jansze M; Willers JM
    Immunology; 1987 Jan; 60(1):141-6. PubMed ID: 2880796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvants designed for veterinary and human vaccines.
    Aucouturier J; Dupuis L; Ganne V
    Vaccine; 2001 Mar; 19(17-19):2666-72. PubMed ID: 11257407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines.
    Aucouturier J; Dupuis L; Deville S; Ascarateil S; Ganne V
    Expert Rev Vaccines; 2002 Jun; 1(1):111-8. PubMed ID: 12908518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvants in veterinary vaccines: modes of action and adverse effects.
    Spickler AR; Roth JA
    J Vet Intern Med; 2003; 17(3):273-81. PubMed ID: 12774966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of vaccine adjuvant muramyldipeptides. 3. Processing optimization, characterization, and bioactivity of an emulsion vehicle.
    Lidgate DM; Fu RC; Byars NE; Foster LC; Fleitman JS
    Pharm Res; 1989 Sep; 6(9):748-52. PubMed ID: 2813271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Fatty Acid Addition to Oil-in-water Emulsions Stabilized with Sucrose Fatty Acid Ester.
    Watanabe T; Kawai T; Nonomura Y
    J Oleo Sci; 2018 Mar; 67(3):307-313. PubMed ID: 29459510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioconjugation Approaches to Producing Subunit Vaccines Composed of Protein or Peptide Antigens and Covalently Attached Toll-Like Receptor Ligands.
    Xu Z; Moyle PM
    Bioconjug Chem; 2018 Mar; 29(3):572-586. PubMed ID: 28891637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable oil-in-water emulsions: preparation and use as vaccine vehicles for lipophilic adjuvants.
    Woodard LF; Jasman RL
    Vaccine; 1985 Jun; 3(2):137-44. PubMed ID: 4036272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.